SAWAI GROUP HOLDINGS Co., Ltd. (JP:4887) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sawai Group Holdings has secured exclusive marketing rights for a pioneering therapeutic app developed by CureApp Inc. aimed at reducing alcohol intake in Japan. The agreement includes milestone payments up to 4.8 billion yen to CureApp, with future royalties on sales post-launch. This app, which is awaiting regulatory approval, represents Japan’s first medical device of its kind to potentially receive insurance coverage as a digital therapy for alcohol dependence.
For further insights into JP:4887 stock, check out TipRanks’ Stock Analysis page.